Loading provider…
Loading provider…
Medical Oncology Physician in Duarte, CA
NPI: 1285831057Primary Employer
City of Hope - Upland
cityofhope.org
HQ Phone
Get M.D. Joseph's Phone Numberphone_androidMobile
Get M.D. Joseph's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2006 - 2025
City of Hope National Medical Center
Fellowship • Hematology and Medical Oncology
2007 - 2010
Los Angeles County-Harbor-UCLA Medical Center 1
Fellowship • Hematology and Medical Oncology
2007 - 2010
Los Angeles County-Harbor-UCLA Medical Center
Residency • Internal Medicine
2004 - 2007
University of Illinois College of Medicine - Chicago
medicine.uic.edu
Medical School
Until 2004
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial.
Authors: Manish Shah, Ahsan Arozullah, David Ilson, Jaffer Ajani, Manish Shah
Publication Date: 2023-05
Authors: May Cho, Arsen Osipov, Katelyn Atkins, Alexandra Gangi, Alexis Levee, Mitchell Kamrava, Andrew Hendifar, Kevin Waters, Miguel Burch, Jun Gong
Journal: JAMA Netw Open
Publication Date: 2021-12-01
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Olaparib, BIOLOGICAL: Ramucirumab
Lead Sponsor: Seagen Inc.
Intervention / Treatment: DRUG: paclitaxel, DRUG: tucatinib, DRUG: trastuzumab, DRUG: ramucirumab, OTHER: tucatinib placebo, OTHER: trastuzumab placebo
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, DRUG: Irinotecan, DRUG: Berzosertib, PROCEDURE: Endoscopic Biopsy, PROCEDURE: Computed Tomography Assisted Biopsy